Data Tables


Sections I - VIII
I.Summary Tables
II.Deceased and Living Donor Characteristics
III.Deceased Donor Organ Recovery and Disposition
IV.Organ Procurement Organization Tables
V.Kidney Tables
VI.Pancreas Transplant Alone (PTA) Tables
VII.Pancreas After Kidney (PAK) Tables
VIII.Kidney-Pancreas Tables
Sections IX - XV
IX.Liver Tables
X.Intestine Tables
XI.Heart Tables
XII.Lung Tables
XIII.Heart-Lung Tables
XIV.Donor and Recipient Tumor Tables
XV.Supplementary Tables
 Technical Notes and Analytic Methods
 All Data Tables (351 K)



View HTMLView PDF

Section XI

11.1aWaiting List Patient Characteristics at End of Year Heart Waiting List Active Waitlist Patients, 1997 to 2006Table 11.1a (42 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Patient Status
Previous Transplant Same Organ
Time on Waiting List
11.1bWaiting List Patient Characteristics at End of Year Heart Waiting List Active and Inactive Patient Comparison, 2002 to 2006Table 11.1b (37 k)
Age
Diagnosis
Gender
Race
Time on Waiting List
11.2aEvents 7 & 30 Days After Listing 2005 and 2006 Heart Registrations with Initial Status 1ATable 11.2a (20 k)
11.2bEvents 30 Days After Snapshot of Prevalent Waiting List Patients on Heart Waiting List on Jan. 1, 2006Table 11.2b (33 k)
30 Days After Snapshot
60 Days After Snapshot
90 Days After Snapshot
11.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Heart Waiting ListTable 11.3 (50 k)
Age
Blood Type
Diagnosis
Gender
Race
Patient Status
11.4Transplant Recipient Characteristics, 1997 to 2006 Heart RecipientsTable 11.4 (46 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
11.5Incidence of Transplant, 1997 to 2006 Heart Transplants per 1 Million PopulationTable 11.5 (29 k)
11.6aImmunosuppression Use for Induction, 1997 to 2006 Recipients with Heart TransplantsTable 11.6a (29 k)
11.6bImmunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Heart TransplantsTable 11.6b (31 k)
11.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Heart TransplantsTable 11.6c (29 k)
11.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Heart TransplantsTable 11.6d (30 k)
11.6eImmunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Heart TransplantsTable 11.6e (31 k)
11.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Heart TransplantsTable 11.6f (31 k)
11.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Heart TransplantsTable 11.6g (31 k)
11.6hPersistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Heart TransplantsTable 11.6h (33 k)
11.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Heart TransplantsTable 11.6i (30 k)
11.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Heart TransplantationTable 11.7 (75 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Age
Procedure Type
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Any Organ
Diagnosis
11.8Adjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 11.8 (36 k)
Age
Gender
Race
Diagnosis
11.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart TransplantsTable 11.9 (22 k)
11.10Unadjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 11.10 (46 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Procedure Type
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
11.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart TransplantsTable 11.11 (22 k)
11.12Adjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 11.12 (36 k)
Age
Gender
Race
Diagnosis
11.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart TransplantsTable 11.13 (22 k)
11.14Unadjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 11.14 (46 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Procedure Type
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
11.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart TransplantsTable 11.15 (22 k)
11.16Prevalence of People Living with a Functioning Transplant at End of Year Heart Recipients, 1997 to 2005Table 11.16 (43 k)
Blood Type
Residency
Gender
Patient Status
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Procedure Type
11.17Transplants by State and Transplant Center, 1997 to 2006 HeartTable 11.17 (70 k)